Pathophysiological Impact of the Adhesion G Protein-coupled Receptor Family

Overview

Journal Am J Physiol Cell Physiol

Publisher American Physiological Society

Specialties Cell Biology
Physiology

Date 2022 Jul 18

PMID 35848619

Authors

Jeanette M Einspahr

Douglas G Tilley

Affiliations

Soon will be listed here.

Abstract

G protein-coupled receptors (GPCRs) represent one of the most targeted drug classes in the human genome, accounting for greater than 40% of all Food and Drug Administration-approved drugs. However, the second-largest family of GPCRs, known as adhesion GPCRs (aGPCR), have yet to serve as a clinical target despite increasing evidence of their physiological and pathological functions, which suggests an opportunity toward the development of novel therapeutics. To date, the pathophysiological function of aGPCRs is associated with a plethora of diseases including cancer, central nervous system disorders, immunity and inflammation, and others. To highlight their potential as pharmacological targets, we will review three distinct aGPCR members (ADGRG1, ADGRE5, and ADGRF5), highlighting their molecular mechanisms of action and contributions to the development of pathophysiology.

Citing Articles

Mendelian randomization of plasma proteomics identifies novel ALS-associated proteins and their GO enrichment and KEGG pathway analyses.

Lu C, Huang X, Huang M, Liu C, Xu J BMC Neurol. 2025; 25(1):82.

PMID: 40033250 PMC: 11874834. DOI: 10.1186/s12883-025-04091-x.

Flamingo participates in multiple models of cell competition.

Bosch P, Cho B, Axelrod J Elife. 2025; 13.

PMID: 39854621 PMC: 11684786. DOI: 10.7554/eLife.98535.

Loss of protein C vs protein S results in discrepant thrombotic phenotypes.

Ku C, Yu X, Zhao Q, Zhao Q, Grzegorski S, Daniel J Blood Adv. 2024; 9(3):545-557.

PMID: 39657127 PMC: 11821410. DOI: 10.1182/bloodadvances.2024013237.

Loss of cardiomyocyte-specific adhesion G-protein-coupled receptor G1 (ADGRG1/GPR56) promotes pressure overload-induced heart failure.

Einspahr J, Xu H, Roy R, Dietz N, Melchior J, Raja J Biosci Rep. 2024; 44(9).

PMID: 39264336 PMC: 11427730. DOI: 10.1042/BSR20240826.

The N terminus-only (trans) function of the adhesion G protein-coupled receptor latrophilin-1 controls multiple processes in reproduction of Caenorhabditis elegans.

Matus D, Post W, Gross V, Knierim A, Kuhn C, Fiedler F G3 (Bethesda). 2024; 14(11).

PMID: 39243387 PMC: 11540312. DOI: 10.1093/g3journal/jkae206.

References

Moreno M, Pedrosa L, Pare L, Pineda E, Bejarano L, Martinez J . GPR56/ADGRG1 Inhibits Mesenchymal Differentiation and Radioresistance in Glioblastoma. Cell Rep. 2017; 21(8):2183-2197. DOI: 10.1016/j.celrep.2017.10.083. View

Georgiadi A, Lopez-Salazar V, Merahbi R, Karikari R, Ma X, Mourao A . Orphan GPR116 mediates the insulin sensitizing effects of the hepatokine FNDC4 in adipose tissue. Nat Commun. 2021; 12(1):2999. PMC: 8137956. DOI: 10.1038/s41467-021-22579-1. View

Kausar T, Sharma R, Hasan M, Tripathi S, Saraya A, Chattopadhyay T . Clinical significance of GPR56, transglutaminase 2, and NF-κB in esophageal squamous cell carcinoma. Cancer Invest. 2010; 29(1):42-8. DOI: 10.3109/07357907.2010.512597. View

Yin Y, Xu X, Tang J, Zhang W, Zhangyuan G, Ji J . CD97 Promotes Tumor Aggressiveness Through the Traditional G Protein-Coupled Receptor-Mediated Signaling in Hepatocellular Carcinoma. Hepatology. 2018; 68(5):1865-1878. DOI: 10.1002/hep.30068. View

Ward Y, Lake R, Martin P, Killian K, Salerno P, Wang T . CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model. Oncogene. 2012; 32(22):2726-38. PMC: 7561260. DOI: 10.1038/onc.2012.301. View

Demberg L, Winkler J, Wilde C, Simon K, Schon J, Rothemund S . Activation of Adhesion G Protein-coupled Receptors: AGONIST SPECIFICITY OF STACHEL SEQUENCE-DERIVED PEPTIDES. J Biol Chem. 2017; 292(11):4383-4394. PMC: 5377759. DOI: 10.1074/jbc.M116.763656. View

Bjarnadottir T, Fredriksson R, Hoglund P, Gloriam D, Lagerstrom M, Schioth H . The human and mouse repertoire of the adhesion family of G-protein-coupled receptors. Genomics. 2004; 84(1):23-33. DOI: 10.1016/j.ygeno.2003.12.004. View

Xu L, Begum S, Hearn J, Hynes R . GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. Proc Natl Acad Sci U S A. 2006; 103(24):9023-8. PMC: 1474142. DOI: 10.1073/pnas.0602681103. View

Sandberg A, Johansson D, Macao B, Hard T . SEA domain autoproteolysis accelerated by conformational strain: energetic aspects. J Mol Biol. 2008; 377(4):1117-29. DOI: 10.1016/j.jmb.2008.01.051. View

10.

Belzeaux R, Gorgievski V, Fiori L, Lopez J, Grenier J, Lin R . GPR56/ADGRG1 is associated with response to antidepressant treatment. Nat Commun. 2020; 11(1):1635. PMC: 7118175. DOI: 10.1038/s41467-020-15423-5. View

11.

Wang T, Ward Y, Tian L, Lake R, Guedez L, Stetler-Stevenson W . CD97, an adhesion receptor on inflammatory cells, stimulates angiogenesis through binding integrin counterreceptors on endothelial cells. Blood. 2004; 105(7):2836-44. DOI: 10.1182/blood-2004-07-2878. View

12.

Tseng W, Wu Y, Yang T, Chiang N, Tsai W, Gordon S . High levels of soluble GPR56/ADGRG1 are associated with positive rheumatoid factor and elevated tumor necrosis factor in patients with rheumatoid arthritis. J Microbiol Immunol Infect. 2017; 51(4):485-491. DOI: 10.1016/j.jmii.2016.11.010. View

13.

Vizurraga A, Adhikari R, Yeung J, Yu M, Tall G . Mechanisms of adhesion G protein-coupled receptor activation. J Biol Chem. 2020; 295(41):14065-14083. PMC: 7549034. DOI: 10.1074/jbc.REV120.007423. View

14.

Hamann J, Aust G, Arac D, Engel F, Formstone C, Fredriksson R . International Union of Basic and Clinical Pharmacology. XCIV. Adhesion G protein-coupled receptors. Pharmacol Rev. 2015; 67(2):338-67. PMC: 4394687. DOI: 10.1124/pr.114.009647. View

15.

Tang X, Jin R, Qu G, Wang X, Li Z, Yuan Z . GPR116, an adhesion G-protein-coupled receptor, promotes breast cancer metastasis via the Gαq-p63RhoGEF-Rho GTPase pathway. Cancer Res. 2013; 73(20):6206-18. DOI: 10.1158/0008-5472.CAN-13-1049. View

16.

Yang D, Zhou Q, Labroska V, Qin S, Darbalaei S, Wu Y . G protein-coupled receptors: structure- and function-based drug discovery. Signal Transduct Target Ther. 2021; 6(1):7. PMC: 7790836. DOI: 10.1038/s41392-020-00435-w. View

17.

Shashidhar S, Lorente G, Nagavarapu U, Nelson A, Kuo J, Cummins J . GPR56 is a GPCR that is overexpressed in gliomas and functions in tumor cell adhesion. Oncogene. 2005; 24(10):1673-82. DOI: 10.1038/sj.onc.1208395. View

18.

Kubo F, Ariestanti D, Oki S, Fukuzawa T, Demizu R, Sato T . Loss of the adhesion G-protein coupled receptor ADGRF5 in mice induces airway inflammation and the expression of CCL2 in lung endothelial cells. Respir Res. 2019; 20(1):11. PMC: 6337809. DOI: 10.1186/s12931-019-0973-6. View

19.

Bondarev A, Attwood M, Jonsson J, Chubarev V, Tarasov V, Schioth H . Opportunities and challenges for drug discovery in modulating Adhesion G protein-coupled receptor (GPCR) functions. Expert Opin Drug Discov. 2020; 15(11):1291-1307. DOI: 10.1080/17460441.2020.1791075. View

20.

Sud N, Sharma R, Ray R, Chattopadhyay T, Ralhan R . Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinoma. Cancer Lett. 2005; 233(2):265-70. DOI: 10.1016/j.canlet.2005.03.018. View